Improving CD4+ lymphocyte counts in HIV-infected hemophilia patients. A favorable prognostic indicator?

Immunol Lett. 1991 Sep;30(1):27-30. doi: 10.1016/0165-2478(91)90085-o.

Abstract

CD4+ lymphocyte counts of 91 HIV+ hemophilia patients were monitored for a mean of 4 years (range: 15-69 months). CD4+ lymphocytes decreased in 55 but increased in 36 patients over time. The CD4+ cell increases were persistent in 5 patients, whereas they fluctuated in 31. Of the 36 patients with increasing CD4+ counts 3 developed AIDS and 1 LAS. The other 32 patients were clinically asymptomatic (CDC II), but had immunological abnormalities, such as increased serum neopterin (N = 18) and impaired in vitro T cell responses to pooled allogenic stimulator cells (N = 15) or mitogens (N = 18). In contrast, of the 55 patients whose CD4+ cells decreased, 24 developed AIDS and 5 ARC (P less than 0.0005). Only 2 of these 55 patients had normal mitogen stimulation in vitro and normal serum neopterin levels.

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Antibodies, Monoclonal
  • Autoantibodies / immunology
  • Biopterins / analogs & derivatives
  • Biopterins / blood
  • CD4-CD8 Ratio
  • CD4-Positive T-Lymphocytes*
  • Flow Cytometry
  • HIV Infections / blood*
  • HIV Infections / immunology
  • HIV Seropositivity / blood
  • HIV Seropositivity / immunology
  • Hemophilia A / blood*
  • Humans
  • Leukocyte Count
  • Lymphocyte Activation / immunology
  • Neopterin
  • Prognosis

Substances

  • Antibodies, Monoclonal
  • Autoantibodies
  • Biopterins
  • Neopterin